Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials

E-ISSN： 2151-4658|68|10|1478-1488

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.68, Iss.10, 2016-10, pp. : 1478-1488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1456-1464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

By Hochberg Marc C. Berry Scott Broglio Kristine Rosenblatt Lisa Nadkarni Anagha Trivedi Digisha Hebden Tony

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1213-1222

Informa Healthcare

Access to resources Recommend Favorite

Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta‐Analysis

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 1, 2015-01 ,pp. : 117-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy

By Strehblow Christoph

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Differential risk of herpes zoster infection with biologic agent use in rheumatoid arthritis: comment on the article by Yun et al

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 7, 2015-07 ,pp. : 1041-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite